We are live on ! Find out more
ELV icon

Elevance Health

1,220 hedge funds and large institutions have $80.7B invested in Elevance Health in 2021 Q3 according to their latest regulatory filings, with 87 funds opening new positions, 462 increasing their positions, 419 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 462 | Existing positions reduced: 419

7% more call options, than puts

Call options by funds: $636M | Put options by funds: $592M

0.08% more ownership

Funds ownership: 88.65% → 88.73% (+0.08%)

5% less capital inflows, than outflows

Capital inflows: $4.54B | Capital outflows: $4.76B

6% less first-time investments, than exits

New positions opened: 87 | Existing positions closed: 93

2% less funds holding

Funds holding: 1,240 → 1,220 (-20)

8% less funds holding in top 10

Funds holding in top 10: 36 → 33 (-3)

Holders
1,220
Holders Change
-20
Holders Change %
-1.61%
% of All Funds
21.28%
Holding in Top 10
33
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-8.33%
% of All Funds
0.58%
New
87
Increased
462
Reduced
419
Closed
93
Calls
$636​M
Puts
$592​M
Net Calls
+$43.9​M
Net Calls Change
+$29​M

ELV Hedge Fund Activity: Q3 2021 in Review

1,220 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2021, worth a combined $80.7B — down 2.6% from $82.8B a quarter earlier.

Sellers outnumbered buyers: 93 funds closed out of ELV and 87 opened new positions — a net loss of 6 holders — while 419 trimmed existing stakes and 462 added.

The largest buyer was Altshuler Shaham, opening a new position worth an estimated $387M. The largest seller was T. Rowe Price Associates, cutting an estimated $903M.

  • 1,220 institutional investors held Elevance Health (ELV) as of Q3 2021, down from 1,240 in Q2 2021.
  • Funds reported $80.7B of Elevance Health stock for Q3 2021, down 2.6% quarter-over-quarter.
  • 87 funds opened new Elevance Health positions in Q3 2021 and 93 closed out, a net change of -6 holders.
  • The largest Elevance Health buyer in Q3 2021 was Altshuler Shaham, an estimated $387M added.
  • The largest Elevance Health seller in Q3 2021 was T. Rowe Price Associates, an estimated $903M sold.

Based on aggregated 13F filings for Q3 2021.